Evidence suggests that IGFBP7 acts as an oncosuppressor gene in prostate, breast, lung, and colorectal cancer due to its regulatory action related to cell proliferation, cell adhesion, cell senescence, and angiogenesis57,58. This evidence concerns the gene IGFBP7 and colorectal cancer.